nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—L-DOPA—Liothyronine—hypothyroidism	0.795	1	CrCrCtD
Masoprocol—CYP19A1—corpus luteum—hypothyroidism	0.0192	0.139	CbGeAlD
Masoprocol—CYP19A1—seminiferous tubule of testis—hypothyroidism	0.0163	0.118	CbGeAlD
Masoprocol—IGF1R—Endochondral Ossification—THRA—hypothyroidism	0.0063	0.0951	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—PAX8—hypothyroidism	0.00615	0.0928	CbGpPWpGaD
Masoprocol—LTB4R—heart—hypothyroidism	0.00529	0.0381	CbGeAlD
Masoprocol—LTB4R—pituitary gland—hypothyroidism	0.00442	0.0319	CbGeAlD
Masoprocol—IGF1R—heart—hypothyroidism	0.00437	0.0315	CbGeAlD
Masoprocol—IGF1R—cardiovascular system—hypothyroidism	0.00412	0.0297	CbGeAlD
Masoprocol—LTB4R—adrenal gland—hypothyroidism	0.00395	0.0285	CbGeAlD
Masoprocol—LTB4R—blood—hypothyroidism	0.00395	0.0285	CbGeAlD
Masoprocol—LTB4R—thyroid gland—hypothyroidism	0.00381	0.0275	CbGeAlD
Masoprocol—IGF1R—gonad—hypothyroidism	0.00374	0.027	CbGeAlD
Masoprocol—LTB4R—female gonad—hypothyroidism	0.00368	0.0265	CbGeAlD
Masoprocol—LTB4R—testis—hypothyroidism	0.00327	0.0235	CbGeAlD
Masoprocol—IGF1R—adrenal gland—hypothyroidism	0.00326	0.0235	CbGeAlD
Masoprocol—IGF1R—blood—hypothyroidism	0.00326	0.0235	CbGeAlD
Masoprocol—IGF1R—thyroid gland—hypothyroidism	0.00315	0.0227	CbGeAlD
Masoprocol—LTB4R—liver—hypothyroidism	0.00309	0.0223	CbGeAlD
Masoprocol—IGF1R—female gonad—hypothyroidism	0.00304	0.0219	CbGeAlD
Masoprocol—CYP2J2—heart—hypothyroidism	0.00296	0.0213	CbGeAlD
Masoprocol—CYP2J2—cardiovascular system—hypothyroidism	0.00279	0.0201	CbGeAlD
Masoprocol—IGF1R—testis—hypothyroidism	0.0027	0.0194	CbGeAlD
Masoprocol—IGF1R—TSH signaling pathway—TSHR—hypothyroidism	0.00268	0.0404	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—TSHB—hypothyroidism	0.00268	0.0404	CbGpPWpGaD
Masoprocol—IGF1R—liver—hypothyroidism	0.00255	0.0184	CbGeAlD
Masoprocol—IGF1R—cerebellum—hypothyroidism	0.00249	0.0179	CbGeAlD
Masoprocol—IGF1R—Integrins in angiogenesis—PIK3C2A—hypothyroidism	0.00248	0.0374	CbGpPWpGaD
Masoprocol—CYP2J2—pituitary gland—hypothyroidism	0.00247	0.0178	CbGeAlD
Masoprocol—ALOX5—heart—hypothyroidism	0.00233	0.0168	CbGeAlD
Masoprocol—ALOX5—cardiovascular system—hypothyroidism	0.0022	0.0159	CbGeAlD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—IGF1—hypothyroidism	0.00219	0.0331	CbGpPWpGaD
Masoprocol—CYP2J2—thyroid gland—hypothyroidism	0.00213	0.0154	CbGeAlD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—PIK3C2A—hypothyroidism	0.00201	0.0303	CbGpPWpGaD
Masoprocol—IGF1R—IGF1 pathway—IGF1—hypothyroidism	0.00189	0.0286	CbGpPWpGaD
Masoprocol—CYP2J2—testis—hypothyroidism	0.00183	0.0132	CbGeAlD
Masoprocol—ALOX5—adrenal gland—hypothyroidism	0.00174	0.0125	CbGeAlD
Masoprocol—ALOX5—blood—hypothyroidism	0.00174	0.0125	CbGeAlD
Masoprocol—CYP2J2—liver—hypothyroidism	0.00173	0.0125	CbGeAlD
Masoprocol—IGF1R—Integrins in angiogenesis—VAV3—hypothyroidism	0.0017	0.0257	CbGpPWpGaD
Masoprocol—CYP2J2—cerebellum—hypothyroidism	0.00169	0.0122	CbGeAlD
Masoprocol—ALOX5—thyroid gland—hypothyroidism	0.00168	0.0121	CbGeAlD
Masoprocol—ALOX5—female gonad—hypothyroidism	0.00162	0.0117	CbGeAlD
Masoprocol—LTB4R—G alpha (q) signalling events—TRH—hypothyroidism	0.00154	0.0232	CbGpPWpGaD
Masoprocol—IGF1R—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.00148	0.0223	CbGpPWpGaD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—IGF1—hypothyroidism	0.00145	0.0219	CbGpPWpGaD
Masoprocol—ALOX5—testis—hypothyroidism	0.00144	0.0104	CbGeAlD
Masoprocol—CYP19A1—gonad—hypothyroidism	0.00138	0.00995	CbGeAlD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00137	0.0207	CbGpPWpGaD
Masoprocol—ALOX5—liver—hypothyroidism	0.00136	0.00981	CbGeAlD
Masoprocol—ALOX5—cerebellum—hypothyroidism	0.00133	0.00958	CbGeAlD
Masoprocol—CYP19A1—adrenal gland—hypothyroidism	0.0012	0.00868	CbGeAlD
Masoprocol—CYP19A1—blood—hypothyroidism	0.0012	0.00867	CbGeAlD
Masoprocol—IGF1R—Insulin Signaling—PIK3C2A—hypothyroidism	0.00117	0.0177	CbGpPWpGaD
Masoprocol—CYP19A1—thyroid gland—hypothyroidism	0.00116	0.00837	CbGeAlD
Masoprocol—CYP19A1—female gonad—hypothyroidism	0.00112	0.00809	CbGeAlD
Masoprocol—IGF1R—SHP2 signaling—IGF1—hypothyroidism	0.00112	0.0169	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—IGF1—hypothyroidism	0.00105	0.0158	CbGpPWpGaD
Masoprocol—IGF1R—Endochondral Ossification—IGF1—hypothyroidism	0.00103	0.0156	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00102	0.0153	CbGpPWpGaD
Masoprocol—CYP19A1—testis—hypothyroidism	0.000995	0.00718	CbGeAlD
Masoprocol—CYP19A1—liver—hypothyroidism	0.000941	0.00678	CbGeAlD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000906	0.0137	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000906	0.0137	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000831	0.0126	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—IGF1—hypothyroidism	0.000831	0.0126	CbGpPWpGaD
Masoprocol—CYP2J2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00083	0.0125	CbGpPWpGaD
Masoprocol—CYP19A1—Endogenous sterols—POMC—hypothyroidism	0.000821	0.0124	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—AVP—hypothyroidism	0.000806	0.0122	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—IGF1—hypothyroidism	0.000794	0.012	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—TRH—hypothyroidism	0.000774	0.0117	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IGF1—hypothyroidism	0.000773	0.0117	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000721	0.0109	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.000696	0.0105	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—TSHB—hypothyroidism	0.00069	0.0104	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—TSHR—hypothyroidism	0.00069	0.0104	CbGpPWpGaD
Masoprocol—CYP2J2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000673	0.0102	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.000615	0.00929	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000534	0.00806	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—TRH—hypothyroidism	0.000438	0.0066	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—IGF1—hypothyroidism	0.000433	0.00653	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—IYD—hypothyroidism	0.000422	0.00637	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—AVP—hypothyroidism	0.000407	0.00614	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—TRH—hypothyroidism	0.000397	0.006	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—TSHB—hypothyroidism	0.00039	0.00589	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—TSHR—hypothyroidism	0.00039	0.00589	CbGpPWpGaD
Masoprocol—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000381	0.00576	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—IYD—hypothyroidism	0.000376	0.00568	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ATP5O—hypothyroidism	0.000359	0.00541	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—POMC—hypothyroidism	0.000358	0.0054	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000355	0.00536	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—TSHB—hypothyroidism	0.000354	0.00535	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—TSHR—hypothyroidism	0.000354	0.00535	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TPO—hypothyroidism	0.000337	0.00509	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ATP5O—hypothyroidism	0.00032	0.00483	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000312	0.00472	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000309	0.00467	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TPO—hypothyroidism	0.000301	0.00454	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000279	0.0042	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CLTC—hypothyroidism	0.000272	0.0041	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—POMC—hypothyroidism	0.00027	0.00408	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—VAV3—hypothyroidism	0.000239	0.0036	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TRH—hypothyroidism	0.000235	0.00354	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CLTC—hypothyroidism	0.000231	0.00349	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AVP—hypothyroidism	0.00023	0.00347	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—VAV3—hypothyroidism	0.000217	0.00327	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TSHR—hypothyroidism	0.000209	0.00316	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TSHB—hypothyroidism	0.000209	0.00316	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AVP—hypothyroidism	0.000209	0.00315	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TRH—hypothyroidism	0.0002	0.00301	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—IYD—hypothyroidism	0.000194	0.00292	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SH2B3—hypothyroidism	0.000186	0.00281	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TSHR—hypothyroidism	0.000178	0.00269	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TSHB—hypothyroidism	0.000178	0.00269	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ATP5O—hypothyroidism	0.000165	0.00249	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—POMC—hypothyroidism	0.000164	0.00248	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SH2B3—hypothyroidism	0.000159	0.00239	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TSHB—hypothyroidism	0.000156	0.00236	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TPO—hypothyroidism	0.000155	0.00234	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—POMC—hypothyroidism	0.000153	0.00231	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000143	0.00217	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TSHB—hypothyroidism	0.000139	0.0021	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3C2A—hypothyroidism	0.000139	0.0021	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—POMC—hypothyroidism	0.000139	0.00209	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PRL—hypothyroidism	0.000138	0.00209	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000137	0.00207	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VAV3—hypothyroidism	0.000128	0.00193	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3C2A—hypothyroidism	0.000124	0.00187	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AVP—hypothyroidism	0.000123	0.00186	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000122	0.00185	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PRL—hypothyroidism	0.000118	0.00178	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC5A5—hypothyroidism	0.000117	0.00176	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VAV3—hypothyroidism	0.000109	0.00164	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AVP—hypothyroidism	0.000105	0.00158	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC5A5—hypothyroidism	0.000104	0.00157	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—POMC—hypothyroidism	8.19e-05	0.00124	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1—hypothyroidism	7.88e-05	0.00119	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TSHB—hypothyroidism	7.17e-05	0.00108	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—POMC—hypothyroidism	6.97e-05	0.00105	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF1—hypothyroidism	6.7e-05	0.00101	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3C2A—hypothyroidism	6.39e-05	0.000965	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.3e-05	0.000952	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—POMC—hypothyroidism	6.12e-05	0.000923	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—POMC—hypothyroidism	5.45e-05	0.000823	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC5A5—hypothyroidism	5.37e-05	0.00081	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—POMC—hypothyroidism	2.81e-05	0.000424	CbGpPWpGaD
